Performance Measurement Network

Question: How does new Prevnar recommendation affect Pneumovax administration?

How does the new ACIP recommendation to give Prevnar 13 to immunocompromised and asplenic patients affect the JACHP standard of administration of Pneumovax vaccine before discharge. Are patients considered exempt from Pneumovax if they recieved Prevnar 13 <8 weeks ago.

Answer:

The pneumonia vaccine measure (IMM-1 no longer specifies either the 13 or 23 vaccine; it is expected that each clinician will order the most appropriate vaccine for each of their patients, according to the new ACIP recommendation. Please review the measure in version 4.2 of the Specifications Manual for full details.)

Question Details
Focus area(s): Chart Abstracted Measure Specifications – Clinical
Related documents: IMM,
File: TABLE-Prevnar13.docx

Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback